Colon-targeted celecoxib ameliorates TNBS-induced rat colitis: A potential pharmacologic mechanism and therapeutic advantages
Authors:
- Yonghyun LeeYLYonghyun Lee
- Wooseong KimWKWooseong Kim
- Sungchae HongSHSungchae Hong
- Huijeong ParkHPHuijeong Park
- Soohwan YumSYSoohwan Yum
- Jeong-Hyun YoonJYJeong-Hyun Yoon
- Yunjin JungYJYunjin Jung
- 1 March 2014
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 726, 49-56
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Science and Technology (2012R1A1A2003641)
- National Research Foundation of Korea
This publication has 32 references indexed in Scilit:
- Persistent Cyclooxygenase-2 Inhibition Downregulates NF-κB, Resulting in Chronic Intestinal Inflammation in the Min/+ Mouse Model of Colon TumorigenesisCancer Research, 2010
- Role of cytokines in inflammatory bowel diseaseWorld Journal of Gastroenterology, 2008
- Aggravation by Selective COX-1 and COX-2 Inhibitors of Dextran Sulfate Sodium (DSS)-Induced Colon Lesions in RatsDigestive Diseases and Sciences, 2007
- Safety of Celecoxib in Patients With Ulcerative Colitis in Remission: A Randomized, Placebo-Controlled, Pilot StudyClinical Gastroenterology and Hepatology, 2006
- Does celecoxib use increase the risk of cardiovascular events?Gastroenterology, 2005
- Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma PreventionNew England Journal of Medicine, 2005
- The selective cyclooxygenase-2 inhibitor celecoxib modulates the formation of vasoconstrictor eicosanoids and activates PPARγ. Influence of albuminJournal of Hepatology, 2005
- Selective Inhibition of Cyclooxygenase-2 Enhances Platelet Adhesion in Hamster Arterioles In VivoCirculation, 2004
- NF-κB regulation in the immune systemNature Reviews Immunology, 2002
- Role of NF-κB in immune and inflammatory responses in the gutGut, 1998